# US 2017/0363622 A1 · Enzyme-Linked Immunosorbent Assay (ELISA) for the Detection of Anti-Mycoplasma hyorhinis IgG in Swine Serum

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2017/0363622 A1
- Document ID: US20170363622A1
- Status: Published application
- Kind: A1
- Application number: 15/533,345
- Filed: 2015-12-07
- Published: 2017-12-21
- Earliest claimed: 2014-12-05
- Assignees: Merial Limited
- Applicants: Merial Inc.
- Inventors: Paulraj Lawrence; Russell F. Bey; Mike Stoll; Eric Bumgardner; Douglas Stine
- Web page: https://patentgrep.com/patent/US20170363622A1

## CPC

- G01N 33/56933: {Mycoplasma}
- C07K 14/30: from Mycoplasmatales, e.g. Pleuropneumonia-like organisms [PPLO]
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

This disclosure presents an Enzyme-Linked Immunosorbent Assay (ELISA) for the selective detection of anti-Mycoplasma hyorhinis IgG in porcine serum, which may contain antibodies specific to multiple other Mycoplasma spp.

## Claims

### Claim 1

A purified, recombinant, non-naturally occurring, non-post-translationally modified, Mycoplasma hyorhinis (M. hyorhinis) p37 polypeptide having a sequence with at least 98% identity to the sequence as set forth in SEQ ID NO:5; wherein the polypeptide is useful for the selective detection of M. hyorhinis antibodies.

### Claim 2 (depends on 1)

The polypeptide of claim 1, wherein the polypeptide has the sequence as set forth in SEQ ID NO:5.

### Claim 3 (depends on 1, 2)

An Enzyme-Linked Immunosorbent Assay kit comprising the polypeptide of claim 1 or 2.

### Claim 4 (depends on 1, 2, 3)

A method for making an ELISA plate, for use as a component of the kit of claim 3, comprising the following steps:
a) suspending the polypeptide of claim 1 or 2 in carbonate/bicarbonate buffer to a concentration of about 80 μg/mL to about 120 μg/mL, to produce a coating solution;
b) adding from about 80 μL to about 120 μL of the coating solution to each well;
c) incubating the plate for at least about 12 hours at about 4° C.;
d) removing the coating solution;
e) blocking the plate;
f) washing the plate; thereby preparing the ELISA assay plate.

### Claim 5 (depends on 4)

A method for selectively detecting the presence of M. hyorhinis in a sample comprising the following steps:
a) providing the ELISA plate of claim 4;
b) providing at least an experimental sample, at least one negative control sample, and at least one sample containing antibodies specific to at least one Mycoplasma species other than M. hyorhinis;
c) diluting the sample(s) in blocking buffer;
d) adding an amount of diluted sample(s) into the wells of the plate;
e) incubating the plates;
f) washing the wells of the plates to remove the diluted sample(s);
g) developing the plates using a chromogen;
h) stopping the chromogen reaction;
i) reading the plate at a wavelength appropriate for the chromogen used;
j) collecting and recording the absorbance data for the wells;
k) determining that M. hyorhinis is present where the sample has significantly more absorbance than the negative control samples; thereby selectively detecting the presence of M. hyorhinis in the sample(s).

### Claim 6 (depends on 1, 2)

A method for selectively detecting the presence of M. hyorhinis P37 antibodies in a test sample, comprising the steps of:
a) providing a test sample suspected of containing P37 antibodies;
b) adding a quantity of the polypeptide of claim 1 or 2 to the test sample, the quantity being sufficient to produce a detectable level of binding activity by anti-P37 antibodies in the test sample; and
c) detecting the presence of P37 antibodies bound to said polypeptide in the test sample.

### Claim 7 (depends on 1, 2)

A method for selectively detecting the presence of M. hyorhinis P37 antibodies in a test sample, comprising the steps of:
a) providing a test sample suspected of containing P37 antibodies;
b) adding a quantity of an immunogenic fragment of the polypeptide of claim 1 or claim 2 to the test sample, the quantity being sufficient to produce a detectable level of binding activity by anti-P37 antibodies in the test sample; and
c) detecting the presence of P37 antibodies bound to said polypeptide in the test sample.

### Claim 8

A diagnostic kit for the selective diagnosis of the presence in a biological sample of M. hyorhinis P37 antibodies; wherein even if the biological sample contains M. hyosynoviae and M. hyopneumoniae antibodies against orthologous, homologous or paralogous P37, the kit will not yield a positive result unless M. hyorhinis antibodies are present.

### Claim 9 (depends on 1, 2, 8)

The kit of claim 8, comprising the polypeptide of claim 1 or 2.

### Claim 10

A method of detecting exposure to M. hyorhinis in an animal or in a biological sample from said animal, the method comprising the step of detecting the presence or absence of an immune response to the polypeptide having the amino acid sequence shown as SEQ ID NO:5.
